Developer docs
API playgroundTry for free, no card

Search company profiles

MAG & More

Full company profile

uuid000q2gt

Namestring
MAG & More
Legal namestring
MAG & More GmbH
Websiteurl
magandmore.com
Company typeenum
Private
Founded yearint
2002
Descriptiontext

MAG & More GmbH is a Munich-based medical device company founded in 2002 that designs, manufactures, and sells Transcranial Magnetic Stimulation (TMS) systems for clinical therapy and neuroscience research. The company has been a wholly-owned subsidiary of the publicly listed neurocare group AG since 2021 and operates from its headquarters on Machtlfinger Strasse 13 in Munich. Its product portfolio spans the Apollo TMS Therapy System (FDA 510(k) cleared for Major Depressive Disorder, with an additional clearance for adolescent MDD) and the PowerMAG Touch clinical system, the PowerMAG Research stimulator series (lab, EEG, ppTMS, and QPS variants) for neuroscience laboratories, the View! 3D MR-based neuronavigation system, and the Stimware integrated treatment software. Proprietary coil technology — including the aCool air-cooled coil (over 20,000 pulses at 1 Hz/75%) and the pCool coil with patented safety limit features supporting up to 100 Hz theta burst stimulation — combined with ISO 13485 manufacturing in Germany underpins the technical differentiation.

The company primarily serves two customer segments. First, clinical practices and healthcare providers — psychiatrists, psychologists, and medical clinics — that deploy TMS for treatment-resistant major depressive disorder, schizophrenia with auditory hallucinations, stroke rehabilitation, anxiety disorders, neuropathic pain, tinnitus, and migraine; the Apollo system's ~19-minute Theta Burst sessions and automatic motor threshold determination are positioned for clinical workflow efficiency. Second, research institutions and universities using PowerMAG stimulators for neuroscience studies, often integrating TMS with EEG, EMG, and MRI methodologies via the Double Coil PMD45-EEG and View! neuronavigation.

Revenue is generated predominantly through direct hardware sales of TMS systems, replacement and additional coils, and complementary accessories (treatment chairs, positioning arms, trolley, TMS field probe), supplemented by professional services (on-site installation, training led by Dr. Wolfgang Strube, and structured training courses) and managed service/support packages. Pricing is quote-based with multi-year service contracts. Distribution is a direct enterprise field-sales motion with a dedicated sales and service contact infrastructure, augmented by referral flow from the parent neurocare group's global therapy center network. Reimbursement eligibility in the US, Australia, Japan, and parts of Europe supports commercial pull-through in those geographies.

Short descriptiontext

MAG & More GmbH, founded in 2002 in Munich, develops Transcranial Magnetic Stimulation (TMS) systems for treating depression and neurological conditions and for neuroscience research. A neurocare group AG subsidiary since 2021, it serves healthcare providers and research institutions globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMünchen, Germany
HQ citystring
München
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
transcranial magnetic stimulation, TMS therapy systems, neurostimulation devices, TMS research stimulators, neuronavigation systems
Industry1 code
PRIMARYHLAHAEAK
Implantable Neuromodulation & Neurostimulation (SCS/DBS/VNS/PNS)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Transcranial Magnetic Stimulation Medical Devices
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1TMS Hardware Systems
TypeHardware Sales
Description

Sale of TMS therapy and research systems including Apollo TMS, PowerMAG Touch, and PowerMAG Research stimulators. Hardware sales represent core revenue with one-time purchase model for equipment.

magandmore.com
2TMS Coils and Accessories
TypeHardware Sales
Description

Replacement and additional coils (aCool, pCool, PMR, PMD70, PMD45-EEG) and accessories sold to existing customers. Repeat purchase opportunity as coils wear over time.

magandmore.com
3Professional Services and Training
TypeProfessional Services
Description

On-site installation, system training, and practical TMS courses offered. Complete Apollo TMS package includes installation, training, and full system warranty. TMS training courses conducted by Dr. Wolfgang Strube.

magandmore.com
4Service and Support Packages
TypeManaged Services
Description

Service packages offering the right solution for individual customer requirements. Service department available for ongoing support and maintenance.

magandmore.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales
Pricing details1 tier
1Enterprise medical device pricing - quote-based
ModelOtherBilling cadenceMulti-year contract
Notes

Medical device pricing requires consultation with sales team. Products include TMS therapy systems, research stimulators, coils, and accessories. Service packages available for ongoing support.

magandmore.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1Apollo TMS
Description

Next generation TMS therapy system for depression treatment with modern user-friendly features and industry-leading biphasic pulse width.

magandmore.com
+4 more records
Core offering1 text field

MAG & More GmbH designs, manufactures and sells Transcranial Magnetic Stimulation (TMS) systems for clinical therapy and neuroscience research. The portfolio includes the Apollo TMS Therapy System and PowerMAG Touch for treating depression and other neurological conditions, the PowerMAG Research stimulator series for research, the View! 3D neuronavigation system for precise coil targeting, the Stimware software platform for treatment control, and a family of cooled and specialty stimulation coils. Products are manufactured in Germany under ISO 13485 with CE Class IIa certification and FDA 510(k) clearance.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Two out of three patients benefit from TMS treatment for depression
+2 more records
Product overview1 text field

MAG & More offers a comprehensive portfolio of Transcranial Magnetic Stimulation (TMS) products for clinical therapy and neuroscience research. The clinical portfolio centers on the Apollo TMS Therapy System and PowerMAG Touch for treating depression and other neurological conditions, supported by the PowerMAG View! 3D Neuronavigation for precision targeting and Stimware software for treatment management. The research portfolio includes the PowerMAG Research stimulator series (in multiple variants including lab, EEG, ppTMS, and QPS models) designed for combining TMS with EEG, EMG, and MRI methodologies. Both portfolios share compatible coil accessories (aCool, pCool, PMR, PMD70, PMD45-EEG) and complementary accessories (treatment chairs, positioning equipment), all managed through the unified Stimware software platform. Products are manufactured in Germany under ISO 13485 quality management with CE Class IIa medical device certification.

Product and service2 records
1Apollo TMS Therapy System
CategoryClinical TMS Therapy System
Description

Clinical TMS system for treating Major Depressive Disorder, featuring industry-leading biphasic pulse width, intuitive touchscreen interface, automatic motor threshold determination, and treatment sessions of approximately 19 minutes. FDA 510(k) cleared and CE Class IIa certified for clinical psychiatrists, psychologists, and medical clinics.

2PowerMAG Touch TMS Therapy System
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

MAG & More GmbH has been part of neurocare group AG since 2021. The company maintains its operations in Munich while benefiting from the broader neurocare group's resources and market presence. neurocare group is a global provider of TMS therapy services and technology.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-based, publicly listed manufacturer of NeuroStar, the leading FDA-cleared TMS system for depression. Directly competes with MAG & More's Apollo and PowerMAG Touch in clinical psychiatry practices and is the dominant US incumbent.

TypeDirect peer
Description

Israel-based, publicly listed company offering Deep TMS systems (H-coil) with FDA-cleared indications including MDD and OCD. Competes head-to-head with MAG & More in clinical TMS, with broader FDA-cleared indications.

3Magstim
TypeDirect peer
Description

UK-based pioneer of TMS stimulators (founded alongside the original Magstim technology) supplying both clinical and research TMS systems globally. Overlaps directly with MAG & More's Apollo/PowerMAG clinical and research product lines.

TypeDirect peer
Description

Denmark-based manufacturer of MagPro TMS systems for clinical and research use. A near-direct competitor in clinical depression TMS and neuroscience research stimulators, with similar European manufacturing heritage.

TypeBroad incumbent
Description

German, publicly listed parent of MAG & More that also operates a global network of TMS therapy centers. Comparable as a TMS ecosystem player, but broader as a services provider rather than a pure-device OEM.

6Neurosoft
TypeDirect peer
Description

Russia-based manufacturer of clinical TMS systems (Neuro-MS/D) sold internationally. Direct competitor in clinical TMS hardware with overlapping coil and stimulator offerings.

TypeEmerging player
Description

South Korea-based developer of wearable and clinical TMS systems for depression and cognitive disorders. Comparable emerging player with overlapping clinical TMS focus, particularly in Asia.

TypeEmerging player
Description

US-based neuromodulation company developing single-pulse TMS devices (SpringTMS) for migraine and other indications. Comparable as a non-invasive neurostimulation device maker with adjacent clinical use cases (migraine vs. depression).

TypeEmerging player
Description

US-based developer of non-invasive brain stimulation technologies including transcranial direct current stimulation (tDCS) and high-definition systems. Comparable as a non-invasive neuromodulation hardware and research-instrument vendor.

TypeBroad incumbent
Description

Medical device company developing advanced neurostimulation systems (Evoke) for chronic pain and other indications. Comparable as a neuromodulation device maker, though focused on implantable rather than non-invasive approaches.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MAG & More

Transcranial Magnetic Stimulation Medical Devicesmagandmore.com

MAG & More GmbH, founded in 2002 in Munich, develops Transcranial Magnetic Stimulation (TMS) systems for treating depression and neurological conditions and for neuroscience research. A neurocare group AG subsidiary since 2021, it serves healthcare providers and research institutions globally.

What MAG & More does

MAG & More GmbH is a Munich-based medical device company founded in 2002 that designs, manufactures, and sells Transcranial Magnetic Stimulation (TMS) systems for clinical therapy and neuroscience research. The company has been a wholly-owned subsidiary of the publicly listed neurocare group AG since 2021 and operates from its headquarters on Machtlfinger Strasse 13 in Munich. Its product portfolio spans the Apollo TMS Therapy System (FDA 510(k) cleared for Major Depressive Disorder, with an additional clearance for adolescent MDD) and the PowerMAG Touch clinical system, the PowerMAG Research stimulator series (lab, EEG, ppTMS, and QPS variants) for neuroscience laboratories, the View! 3D MR-based neuronavigation system, and the Stimware integrated treatment software. Proprietary coil technology — including the aCool air-cooled coil (over 20,000 pulses at 1 Hz/75%) and the pCool coil with patented safety limit features supporting up to 100 Hz theta burst stimulation — combined with ISO 13485 manufacturing in Germany underpins the technical differentiation.

The company primarily serves two customer segments. First, clinical practices and healthcare providers — psychiatrists, psychologists, and medical clinics — that deploy TMS for treatment-resistant major depressive disorder, schizophrenia with auditory hallucinations, stroke rehabilitation, anxiety disorders, neuropathic pain, tinnitus, and migraine; the Apollo system's ~19-minute Theta Burst sessions and automatic motor threshold determination are positioned for clinical workflow efficiency. Second, research institutions and universities using PowerMAG stimulators for neuroscience studies, often integrating TMS with EEG, EMG, and MRI methodologies via the Double Coil PMD45-EEG and View! neuronavigation.

Revenue is generated predominantly through direct hardware sales of TMS systems, replacement and additional coils, and complementary accessories (treatment chairs, positioning arms, trolley, TMS field probe), supplemented by professional services (on-site installation, training led by Dr. Wolfgang Strube, and structured training courses) and managed service/support packages. Pricing is quote-based with multi-year service contracts. Distribution is a direct enterprise field-sales motion with a dedicated sales and service contact infrastructure, augmented by referral flow from the parent neurocare group's global therapy center network. Reimbursement eligibility in the US, Australia, Japan, and parts of Europe supports commercial pull-through in those geographies.

MAG & More firmographics

Firmographics
Name
MAG & More
Legal name
MAG & More GmbH
Website
https://magandmore.com
Company type
Private
Founded year
2002
Operating status
Operating
Headcount range
11–50 employees
Short description
MAG & More GmbH, founded in 2002 in Munich, develops Transcranial Magnetic Stimulation (TMS) systems for treating depression and neurological conditions and for neuroscience research. A neurocare group AG subsidiary since 2021, it serves healthcare providers and research institutions globally.
Ownership category
akta.pro rank

MAG & More industry classification

Industry
Product category
Transcranial Magnetic Stimulation Medical Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAEAK
Implantable Neuromodulation & Neurostimulation (SCS/DBS/VNS/PNS)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)

Keywords

  • Transcranial magnetic stimulation
  • TMS therapy systems
  • Neurostimulation devices
  • TMS research stimulators
  • Neuronavigation systems

Where MAG & More is headquartered

Location

Headquarters

HQ city
München
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

MAG & More business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

  1. TMS Hardware Systems: Sale of TMS therapy and research systems including Apollo TMS, PowerMAG Touch, and PowerMAG Research stimulators. Hardware sales represent core revenue with one-time purchase model for equipment.
  2. TMS Coils and Accessories: Replacement and additional coils (aCool, pCool, PMR, PMD70, PMD45-EEG) and accessories sold to existing customers. Repeat purchase opportunity as coils wear over time.
  3. Professional Services and Training: On-site installation, system training, and practical TMS courses offered. Complete Apollo TMS package includes installation, training, and full system warranty. TMS training courses conducted by Dr. Wolfgang Strube.
  4. Service and Support Packages: Service packages offering the right solution for individual customer requirements. Service department available for ongoing support and maintenance.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractEnterprise medical device pricing - quote-based

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

MAG & More product offering

Product offering

Core offering

MAG & More GmbH designs, manufactures and sells Transcranial Magnetic Stimulation (TMS) systems for clinical therapy and neuroscience research. The portfolio includes the Apollo TMS Therapy System and PowerMAG Touch for treating depression and other neurological conditions, the PowerMAG Research stimulator series for research, the View! 3D neuronavigation system for precise coil targeting, the Stimware software platform for treatment control, and a family of cooled and specialty stimulation coils. Products are manufactured in Germany under ISO 13485 with CE Class IIa certification and FDA 510(k) clearance.

Product overview

MAG & More offers a comprehensive portfolio of Transcranial Magnetic Stimulation (TMS) products for clinical therapy and neuroscience research. The clinical portfolio centers on the Apollo TMS Therapy System and PowerMAG Touch for treating depression and other neurological conditions, supported by the PowerMAG View! 3D Neuronavigation for precision targeting and Stimware software for treatment management. The research portfolio includes the PowerMAG Research stimulator series (in multiple variants including lab, EEG, ppTMS, and QPS models) designed for combining TMS with EEG, EMG, and MRI methodologies. Both portfolios share compatible coil accessories (aCool, pCool, PMR, PMD70, PMD45-EEG) and complementary accessories (treatment chairs, positioning equipment), all managed through the unified Stimware software platform. Products are manufactured in Germany under ISO 13485 quality management with CE Class IIa medical device certification.

Differentiator

Problem solved

Functional benefit

Brands

  • Apollo TMS: Next generation TMS therapy system for depression treatment with modern user-friendly features and industry-leading biphasic pulse width.
  • PowerMAG Touch
  • PowerMAG Research
  • View! 3D Neuronavigation
  • Stimware

Products and services

  • Apollo TMS Therapy System Clinical TMS system for treating Major Depressive Disorder, featuring industry-leading biphasic pulse width, intuitive touchscreen interface, automatic motor threshold determination, and treatment sessions of approximately 19 minutes. FDA 510(k) cleared and CE Class IIa certified for clinical psychiatrists, psychologists, and medical clinics.
  • PowerMAG Touch TMS Therapy System

Quantifiable outcome

  • Two out of three patients benefit from TMS treatment for depression
  • +2 more outcomes

Companies that use MAG & More

Customer profile

Segments2 records

Ideal customer profiles2 records

MAG & More technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

MAG & More partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • neurocare group AGcoreStrategic or Co-development Partner · 1 January 2021MAG & More GmbH has been part of neurocare group AG since 2021. The company maintains its operations in Munich while benefiting from the broader neurocare group's resources and market presence. neurocare group is a global provider of TMS therapy services and technology.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

MAG & More competitors and assessment

Company assessment

Direct peers

  • Neuronetics: US-based, publicly listed manufacturer of NeuroStar, the leading FDA-cleared TMS system for depression. Directly competes with MAG & More's Apollo and PowerMAG Touch in clinical psychiatry practices and is the dominant US incumbent.
  • Brainsway: Israel-based, publicly listed company offering Deep TMS systems (H-coil) with FDA-cleared indications including MDD and OCD. Competes head-to-head with MAG & More in clinical TMS, with broader FDA-cleared indications.
  • Magstim: UK-based pioneer of TMS stimulators (founded alongside the original Magstim technology) supplying both clinical and research TMS systems globally. Overlaps directly with MAG & More's Apollo/PowerMAG clinical and research product lines.
  • MagVenture: Denmark-based manufacturer of MagPro TMS systems for clinical and research use. A near-direct competitor in clinical depression TMS and neuroscience research stimulators, with similar European manufacturing heritage.
  • Neurosoft: Russia-based manufacturer of clinical TMS systems (Neuro-MS/D) sold internationally. Direct competitor in clinical TMS hardware with overlapping coil and stimulator offerings.

Broad incumbents

  • neurocare group AG: German, publicly listed parent of MAG & More that also operates a global network of TMS therapy centers. Comparable as a TMS ecosystem player, but broader as a services provider rather than a pure-device OEM.
  • Saluda Medical: Medical device company developing advanced neurostimulation systems (Evoke) for chronic pain and other indications. Comparable as a neuromodulation device maker, though focused on implantable rather than non-invasive approaches.

Emerging players

  • Ybrain: South Korea-based developer of wearable and clinical TMS systems for depression and cognitive disorders. Comparable emerging player with overlapping clinical TMS focus, particularly in Asia.
  • eNeura: US-based neuromodulation company developing single-pulse TMS devices (SpringTMS) for migraine and other indications. Comparable as a non-invasive neurostimulation device maker with adjacent clinical use cases (migraine vs. depression).
  • Soterix Medical: US-based developer of non-invasive brain stimulation technologies including transcranial direct current stimulation (tDCS) and high-definition systems. Comparable as a non-invasive neuromodulation hardware and research-instrument vendor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

MAG & More social profiles

Digital presence

MAG & More compliance and trust

Trust signal

Compliance5 records

MAG & More financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MAG & More leadership team

Management profile

Number of profiles

Profiles5 records

MAG & More funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MAG & More M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MAG & More

What does MAG & More do?

MAG & More GmbH designs, manufactures and sells Transcranial Magnetic Stimulation (TMS) systems for clinical therapy and neuroscience research. The portfolio includes the Apollo TMS Therapy System and PowerMAG Touch for treating depression and other neurological conditions, the PowerMAG Research stimulator series for research, the View! 3D neuronavigation system for precise coil targeting, the Stimware software platform for treatment control, and a family of cooled and specialty stimulation coils. Products are manufactured in Germany under ISO 13485 with CE Class IIa certification and FDA 510(k) clearance.

Is MAG & More a public or private company?

MAG & More is a private company. It is classified as corporate owned and is currently operating.

When was MAG & More founded?

MAG & More was founded in 2002. It employs 11 to 50 people.

Where is MAG & More based?

MAG & More is headquartered in München, Germany, in the Europe region.

How does MAG & More make money?

Four revenue lines are on record. TMS Hardware Systems are the primary driver. The others are TMS Coils and Accessories, professional Services and Training and service and Support Packages.

Who are MAG & More's main competitors?

Direct peers on record are Neuronetics, Brainsway, Magstim, MagVenture and Neurosoft. Broad incumbents are neurocare group AG and Saluda Medical. Emerging players are Ybrain, eNeura and Soterix Medical.

Does MAG & More have an API?

No public API is recorded for MAG & More.

What industry is MAG & More in?

MAG & More's product category is Transcranial Magnetic Stimulation Medical Devices. Its primary akta.pro industry code is HLAHAEAK, Implantable Neuromodulation & Neurostimulation (SCS/DBS/VNS/PNS). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales